We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$3.56M
Cap. Flow
-$2.69M
Cap. Flow %
-2.11%
Top 10 Hldgs %
73.57%
Holding
78
New
20
Increased
12
Reduced
12
Closed
22

Top Buys

Rank Stock Value
1
ALMS
Alumis Inc
ALMS
+$4.36M
2
CELC icon
Celcuity
CELC
+$3.08M
3
FCX icon
Freeport-McMoran
FCX
+$2.33M
4
AMZN icon
Amazon
AMZN
+$1.85M
5
AAOI icon
Applied Optoelectronics
AAOI
+$1.65M

Top Sells

Rank Stock Value
1
GPCR icon
Structure Therapeutics
GPCR
+$2.68M
2
FIGR
Figure Technology Solutions
FIGR
+$2.35M
3
SPOT icon
Spotify
SPOT
+$2.32M
4
XOM icon
ExxonMobil
XOM
+$1.82M
5
NUVB icon
Nuvation Bio
NUVB
+$1.79M

Sector Composition

Rank Sector Weight
1 Healthcare 61.65%
2 Energy 24.24%
3 Consumer Discretionary 5.4%
4 Technology 4.57%
5 Materials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
1
Krystal Biotech
KRYS
$10.2B
$15.6M 12.28%
60,477
-23
-0% -$6.12K
CVX icon
2
Chevron
CVX
$387B
$15.5M 12.2%
75,000
-3,500
-4% -$638K
XOM icon
3
ExxonMobil
XOM
$637B
$11.9M 9.33%
70,000
-12,500
-15% -$1.82M
CELC icon
4
Celcuity
CELC
$4.18B
$10.5M 8.22%
91,675
+28,260
+45% +$3.08M
TGTX icon
5
TG Therapeutics
TGTX
$7.95B
$8.27M 6.5%
249,025
-19,850
-7% -$592K
ABVX
6
Abivax
ABVX
$10.6B
$7.89M 6.2%
70,900
+7,000
+11% +$828K
AMZN icon
7
Amazon
AMZN
$2.87T
$6.87M 5.4%
33,000
+8,400
+34% +$1.85M
VKTX icon
8
Viking Therapeutics
VKTX
$3.72B
$6.81M 5.35%
209,300
+3,200
+2% +$103K
ARWR icon
9
Arrowhead Research
ARWR
$11.9B
$5.17M 4.07%
82,500
+7,500
+10% +$475K
NKTR icon
10
Nektar Therapeutics
NKTR
$2.36B
$5.1M 4.01%
70,900
+19,700
+38% +$1.12M
CYTK icon
11
Cytokinetics
CYTK
$10.6B
$4.25M 3.34%
64,500
– –
ALMS
12
Alumis Inc
ALMS
$3.56B
$3.84M 3.02%
+174,250
New +$4.36M
ET icon
13
Energy Transfer Partners
ET
$70B
$2.57M 2.02%
133,100
– –
FCX icon
14
Freeport-McMoran
FCX
$89B
$2.26M 1.78%
+38,500
New +$2.33M
AAOI icon
15
Applied Optoelectronics
AAOI
$7.49B
$2.19M 1.72%
+25,900
New +$1.65M
XENE icon
16
Xenon Pharmaceuticals
XENE
$6.07B
$1.95M 1.53%
+33,500
New +$1.54M
NUVB icon
17
Nuvation Bio
NUVB
$2.22B
$1.24M 0.98%
290,000
-320,500
-52% -$1.79M
STAA icon
18
STAAR Surgical
STAA
$1.2B
$1.04M 0.82%
55,500
– –
PRAX icon
19
Praxis Precision Medicines
PRAX
$8.49B
$870K 0.68%
2,700
+2,000
+286% +$619K
GBTC icon
20
Grayscale Bitcoin Trust
GBTC
$9.41B
$813K 0.64%
15,400
-19,000
-55% -$1.13M
S icon
21
SentinelOne
S
$6.39B
$699K 0.55%
+54,300
New +$754K
LITE icon
22
Lumentum
LITE
$54.7B
$632K 0.5%
+900
New +$494K
BE icon
23
Bloom Energy
BE
$61.2B
$610K 0.48%
4,500
-8,500
-65% -$1.25M
CRGY icon
24
Crescent Energy
CRGY
$3.72B
$608K 0.48%
45,000
-16,312
-27% -$171K
KURA icon
25
Kura Oncology
KURA
$795M
$601K 0.47%
73,900
– –
1
2 3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
IFA
Interactive Financial Advisors New Lenox, Illinois $153M AUM 13.94% 1-Year Est. Return
BGAI
Bruce G. Allen Investments Denver, Colorado $153M AUM 23.23% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
EG
Ellerson Group Annapolis, Maryland $153M AUM 41.08% 1-Year Est. Return

ACT Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, ACT Capital Management held 78 positions worth $127M, up 2.9% from $124M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

ACT Capital Management's Q1 2026 filing shows 20 new, 12 increased, 12 reduced and 22 closed positions. Its largest new stake was Alumis Inc: 174,250 shares worth $3.84M. The largest sale was Structure Therapeutics, an estimated $2.68M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Energy and Consumer Discretionary.

  • ACT Capital Management's largest Q1 2026 buy was Alumis Inc: 174,250 shares worth $3.84M.
  • ACT Capital Management added most to Celcuity in Q1 2026, an estimated $3.08M increase.
  • ACT Capital Management's biggest Q1 2026 reduction was ExxonMobil, cutting an estimated $1.82M.
  • ACT Capital Management fully exited Structure Therapeutics in Q1 2026, selling an estimated $2.68M.
  • ACT Capital Management's ten largest holdings make up 74% of its $127M portfolio in Q1 2026.
  • ACT Capital Management opened 20 new positions and closed 22 in Q1 2026.
  • ACT Capital Management's portfolio value rose 2.9% quarter-over-quarter to $127M.

Based on ACT Capital Management's 13F filing for Q1 2026, filed 8 May 2026.